Clinical Research Directory

Inclusion Criteria: * Age ≥ 18 years. * Metastatic solid tumor or not. * Anemia by functional martial deficiency (as defined in the NCCN2016 recommendations): o Hb \< 11 g/DL, TSAT \< 20% and ferritinlike between 30 and 800 ng/ml * Initial assessment of anemia carried out at the laboratory of Biopathology of the ICO Exclusion Criteria: * Patient with malignant hemopathy. * Patient with chronic renal failure with an estimation of renal filtration rate according to the formula CKD-EPI \< 60 ml/min/1.73 m². * Patient with vitamin B12 deficiency, folate deficiency, hemolysis and/or hemoglobinopathy. * Patient with active infection. * Patient with bone marrow tumor. Confirmation by a osteo-medullary biopsy (BOM) or a myelogram is not necessary to exclude the patient. * Patient who received ASE within two months prior to the initial blood test. * Patient who received iron (oral or injectable) in the two months preceding the initial blood test. * Patient who received a transfusion of globular pellets in the month preceding the initial blood test.